Skip to main content

Animations

MJFF Publications

651 - 660 of 8825 Results
Title
Year
  • Year
  • 2011
  • 2010
  • 2022
  • 2007
  • 2017
  • 2015
  • 2015
  • 2014
  • 2020
  • 2021
  • Summary Details
    RESTRICTED
    Title: α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's Disease
    Journal Name: Pharmacological Reviews
    Publisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1124/pr.110.003269
    Citation Count: 171
  • Summary Details
    RESTRICTED
    Title: Glutamate Receptor Ion Channels: Structure, Regulation, and Function
    Journal Name: Pharmacological Reviews
    Publisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1124/pr.109.002451
    Citation Count: 2923
  • Summary Details
    RESTRICTED
    Title: PARkinson's: From cellular mechanisms to potential therapeutics
    Journal Name: Pharmacology & Therapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.pharmthera.2021.107968
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Human embryonic stem cells for brain repair?
    Journal Name: Philosophical Transactions of the Royal Society B: Biological Sciences
    Publisher: The Royal Society
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1098/rstb.2006.2014
    Citation Count: 34
  • Summary Details
    RESTRICTED
    Title: The Retina in Multiple System Atrophy: Systematic Review and Meta-Analysis
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2017.00206
    Citation Count: 32
  • Summary Details
    RESTRICTED
    Title: Pharmacogenetics of Antipsychotic-Induced Movement Disorders as a Resource for Better Understanding Parkinson’s Disease Modifier Genes
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2015.00027
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: Expanding the Repertoire of Biomarkers for Alzheimer’s Disease: Targeted and Non-targeted Approaches
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2015.00256
    Citation Count: 15
  • Summary Details
    RESTRICTED
    Title: Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2014.00242
    Citation Count: 177
  • Transcranial static magnetic stimulation —From bench to bedside and beyond—
    2020
    Summary Details
    RESTRICTED
    Title: Transcranial static magnetic stimulation —From bench to bedside and beyond—
    Journal Name: Neuroscience Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neures.2019.12.005
    Citation Count: 14
  • Disease modifying therapies for Parkinson's disease: Novel targets
    2021
    Summary Details
    RESTRICTED
    Title: Disease modifying therapies for Parkinson's disease: Novel targets
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108839
    Citation Count: 4
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.